4.5 Article

The Myc 3′ Wnt-Responsive Element Regulates Homeostasis and Regeneration in the Mouse Intestinal Tract

期刊

MOLECULAR AND CELLULAR BIOLOGY
卷 32, 期 19, 页码 3891-3902

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.00548-12

关键词

-

资金

  1. National Institutes of Health grant [R01DK080805]

向作者/读者索取更多资源

The Wnt/beta-catenin signaling pathway controls cellular proliferation in the intestines. In response to Wnt, beta-catenin transits into the nucleus and associates with members of the T-cell factor (TCF) family of transcription factors. beta-Catenin/TCF complexes bind Wnt responsive DNA elements (WREs) to activate target gene expression. The c-MYC proto-oncogene (MYC) is a direct target of beta-catenin/TCF complexes. We recently identified the MYC 3' WRE, which maps 1.4-kb downstream from the MYC transcription stop site. To investigate the role of the Myc 3' WRE in the intestines, we generated a mouse model with a germ line deletion of this element. The intestinal architecture was largely preserved in knockout mice; however, removal of the Myc 3' WRE compromised the crypt microenvironment. In comparison to wild-type intestines, knockout intestines contained an increased number of proliferative cells and a reduced number of differentiated cells comprising both absorptive and secretory lineages. Using a model of colitis, we found that knockout colons repaired more rapidly during the recovery period of the protocol. These results indicate that regulation of MYC expression through the Myc 3' WRE contributes to intestinal homeostasis. Furthermore, our study implicates MYC as an important regulator of intestinal regeneration following injury.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Polysubstance use in inflammatory bowel disease

Kaleb Bogale, Kent Vrana, Wesley Raup-Konsavage, Vonn Walter, August Stuart, Shannon Dalessio, Walter Koltun, Nana Bernasko, Andrew Tinsley, Emmanuelle Williams, Kofi Clarke, Matthew D. Coates

Summary: This study aimed to evaluate the incidence, predisposing factors, and impacts of polysubstance use (PSU) in patients with inflammatory bowel disease (IBD). The results showed that PSU was associated with an increased rate of IBD-associated imaging studies.

JOURNAL OF DIGESTIVE DISEASES (2021)

Review Pharmacology & Pharmacy

Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals

Christopher A. Legare, Wesley M. Raup-Konsavage, Kent E. Vrana

Summary: This review summarizes the therapeutic uses of cannabis and CBD oil. The data support the role of cannabis/cannabinoids in pain relief, seizure disorders, appetite stimulation, muscle spasticity, and treatment of nausea/vomiting, but the data for central nervous system disorders and cancer treatment are less compelling.

PHARMACOLOGY (2022)

Article Physiology

Acute Cannabigerol Administration Lowers Blood Pressure in Mice

Victoria L. Vernail, Sarah S. Bingaman, Yuval Silberman, Wesley M. Raup-Konsavage, Kent E. Vrana, Amy C. Arnold

Summary: Cannabigerol, a compound synthesized by Cannabis sativa, has been found to lower blood pressure by activating alpha 2-adrenoreceptors and inhibiting norepinephrine release. These findings suggest that cannabigerol could be potentially used as a therapeutic for hypertension.

FRONTIERS IN PHYSIOLOGY (2022)

Article Anesthesiology

Cannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy-induced peripheral neuropathy

Diana E. Sepulveda, Daniel P. Morris, Wesley M. Raup-Konsavage, Dongxiao Sun, Kent E. Vrana, Nicholas M. Graziane

Summary: This study demonstrates the effectiveness of CBG in relieving mechanical hypersensitivity caused by cisplatin-induced peripheral neuropathy, but its effects may be limited to specific types of pain.

EUROPEAN JOURNAL OF PAIN (2022)

Article Biochemistry & Molecular Biology

Combinations of Cannabidiol and Δ9-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain

Diana E. Sepulveda, Kent E. Vrana, Nicholas M. Graziane, Wesley M. Raup-Konsavage

Summary: Neuropathic pain, a common and difficult-to-treat condition, has limited response to current therapies. This study found that THC and CBD have different effects on mechanical hypersensitivity in a mouse model of neuropathic pain. High THC extract or pure THC showed the most effective treatment for reducing pain, while high CBD extract had some alleviating effect on mechanical hypersensitivity, but not as potent as high THC extract.

BIOMEDICINES (2022)

Article Biochemistry & Molecular Biology

Efficient Synthesis for Altering Side Chain Length on Cannabinoid Molecules and Their Effects in Chemotherapy and Chemotherapeutic Induced Neuropathic Pain

Wesley M. Raup-Konsavage, Diana E. Sepulveda, Daniel P. Morris, Shantu Amin, Kent E. Vrana, Nicholas M. Graziane, Dhimant Desai

Summary: This study developed a novel synthesis method for producing side chain variants of CBG, which showed potential in reducing neuropathic pain and decreasing colorectal cancer cell viability. This research is significant for studying side chain derivatives of other cannabinoids.

BIOMOLECULES (2022)

Review Biochemistry & Molecular Biology

Secondary Terpenes in Cannabis sativa L.: Synthesis and Synergy

Francisco T. Chacon, Wesley M. Raup-Konsavage, Kent E. Vrana, Joshua J. Kellogg

Summary: This review discusses the diversity and bioactivities of terpenes in cannabis, as well as their potential in modulating the activity of cannabinoids. It also explores the concept of the entourage effect in cannabis and the future of synergy experimentation to understand the interaction between phytochemicals within Cannabis sativa L.

BIOMEDICINES (2022)

Article Substance Abuse

The Rise and Risk of Delta-8 THC (Delta-8-Tetrahydrocannabinol)

Rahul Nachnani, Wesley M. Raup-Konsavage, Kent E. Vrana

Summary: The purpose of this review is to differentiate the effects of delta-8-tetrahydrocannabinol (delta-8) and delta-9-tetrahydrocannabinol (delta-9) on human health and disease. Recent findings show that delta-8 is a novel cannabinoid that is increasingly used, but there are concerns about heavy metal contamination and inconsistent compositions in retail products. The effects of delta-8 on the human body and its pharmacokinetic differences from delta-9 remain largely unexplored.

CURRENT ADDICTION REPORTS (2022)

Editorial Material Biochemistry & Molecular Biology

Special Issue: Therapeutic Potential for Cannabis and Cannabinoids

Wesley M. Raup-Konsavage

BIOMEDICINES (2023)

Article Pharmacology & Pharmacy

Potential Utility of Cannabidiol in Stress-Related Disorders

Nicole A. Lookfong, Wesley M. Raup-Konsavage, Yuval Silberman

Summary: This article discusses the impact of trauma and significant stressors on the endocannabinoid (eCB) system, as well as the potential benefits of using CBD in treating stress-related disorders. Pre-clinical evidence supports CBD as a potential treatment for reducing fearful behavior and promoting extinction of contextual fear memories in PTSD, but further clinical research is needed.

CANNABIS AND CANNABINOID RESEARCH (2023)

Article Pharmacology & Pharmacy

Distinctive Therapeutic Effects of Non-Euphorigenic Cannabis Extracts in Osteoarthritis

Vengadeshprabhu Karuppagounder, Juliet Chung, Ahmed Abdeen, Amy Thompson, Andreas Bouboukas, William J. Pinamont, Natalie K. Yoshioka, Diana E. Sepulveda, Wesley M. Raup-Konsavage, Nicholas M. Graziane, Kent E. Vrana, Reyad A. Elbarbary, Fadia Kamal

Summary: This study found that CBD oil and CBG oil have therapeutic effects in relieving pain and inflammation, improving gait and locomotor activity in OA mice. Additionally, CBG oil has chondroprotective properties.

CANNABIS AND CANNABINOID RESEARCH (2022)

Article Pharmacology & Pharmacy

Inhibition of Sphingosine Kinase Activity Enhances Immunogenic Cell Surface Exposure of Calreticulin Induced by the Synthetic Cannabinoid 5-epi-CP-55,940

Jeremy A. Hengst, Asvelt J. Nduwumwami, Wesley M. Raup-Konsavage, Kent E. Vrana, Jong K. Yun

Summary: This study demonstrates for the first time that cannabinoids can induce immunogenic cell death (ICD), and inhibition of sphingosine kinases (SphKs) can enhance this effect. In addition, targeting SphKs may have the potential to reverse chemotherapy resistance and enhance the antitumor immune response through enhanced ICD induction.

CANNABIS AND CANNABINOID RESEARCH (2022)

Article Pharmacology & Pharmacy

Evaluating the Antinociceptive Efficacy of Cannabidiol Alone or in Combination with Morphine Using the Formalin Test in Male and Female Mice

Diana E. Sepulveda, Daniel P. Morris, Wesley M. Raup-Konsavage, Dongxiao Sun, Kent E. Vrana, Nicholas M. Graziane

Summary: The study found that CBD treatment showed antinociceptive effects in male mice during the first phase of the formalin test, but not in female mice. Additionally, the combination of CBD and morphine did not produce a synergistic antinociceptive response in both male and female mice. Overall, CBD treatment may be more beneficial for males during the acute phase of persistent pain.

CANNABIS AND CANNABINOID RESEARCH (2022)

Article Pharmacology & Pharmacy

Δ8-THC: Legal Status, Widespread Availability, and Safety Concerns

Shanna Babalonis, Wesley M. Raup-Konsavage, Peter D. Akpunonu, Agnes Balla, Kent E. Vrana

Summary: The availability of Delta-8-tetrahydrocannabinol products in the United States has raised legal concerns, as they are currently unregulated despite being classified as a Schedule I drug. The lack of regulation has led to potential health risks, with some individuals misinterpreting the legal status and associated risks.

CANNABIS AND CANNABINOID RESEARCH (2021)

Review Pharmacology & Pharmacy

The Pharmacological Case for Cannabigerol

Rahul Nachnani, Wesley M. Raup-Konsavage, Kent E. Vrana

Summary: Cannabigerol (CBG) is a unique phytocannabinoid with potential therapeutic properties in neurological, inflammatory bowel disease, and antibacterial activities. Despite its commercialization, limited research has been conducted on CBG, necessitating further exploration of its therapeutic uses and potential hazards.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)

暂无数据